Can we predict real T3 stage prostate cancer in patients with clinical T3 (cT3) disease before radical prostatectomy?

Yonsei Medical Journal

Volumn 51, Issue 5, 2010, Pages 700-707

  Lee, Hye Won ^a   Seo, Seong Il ^b   Jeon, Seong Soo ^b   Lee, Hyun Moo ^b   Choi, Han Yong ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CT3; MRI; Prostate cancer; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TUMOR VOLUME; AGED; BLOOD; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSTATIC NEOPLASMS;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 77957969753     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.5.700     Document Type: Review

References (34)

1. Schröder FH, van den Ouden D. Management of locally advanced prostate cancer. 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999. World J Urol 2000;18:204-215.
2. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005;95:751-756.
3. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up.] Arch Esp Urol 2004; 57:679-692.
4. Casey JT, Meeks JJ, Greco KA, Wu SD, Nadler RB. Outcomes of locally advanced (T3 or greater) prostate cancer in men undergoing robot-assisted laparoscopic prostatectomy. J Endourol 2009;23:1519-1522.
5. Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC. Radical prostatectomy for clinical stage T3a disease. Cancer 2007;109:1273-1278.
6. Partin AW, Kattan MW, Subong EH, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445-1451.
7. Stamatiou K, Sofras F. Is the presence of perineural and perivascular invasion a risk factor for positive surgical margins during neurovascular bundle preservation radical prostatectomy procedure? Urol Int 2007;79:189-190.
8. Fütterer JJ. MR imaging in local staging of prostate cancer. Eur J Radiol 2007;63:328-334.
9. Rørvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L, Haukaas S. MRI with an endorectal coil for staging of clinically localized prostate cancer prior of radical prostatectomy. Eur Radiol 1999;9:29-34.
10. van den Ouden D, Hop WC, Schröder FH. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 1998; 160:1392-1397.
11. Van Poppel H, Goethuys H, Callewaert P, Vanuytsel L, Van de Voorde W, Baert L. Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer. Eur Urol 2000; 38:372-379.
12. Reckwiz T, Potter SR, Partin AW. Prediction of locoregional extension and metastatic disease in prostate cancer: a review. World J Urol 2000;18:165-172.
13. van den Ouden D, Davidson PJ, Hop W, Schröder FH. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 1994;151:646-651.
14. Rannikko S, Salo JO. Radical prostatectomy as treatment of localized prostatic cancer. Early results, with special focus on transrectal ultrasound for local staging. Scand J Urol Nephrol 1990;24:103-107.
15. Joniau S, Hsu CY, Lerut E, Van Baelen A, Haustermans K, Roskams T, et al. A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer. Eur Urol 2007;51:388-394.
16. Tewari A, Narayan P. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol 1998;160:430-436.
17. Ehreth JT, Miller JI, McBeath RB, Hansen KK, Ahmann FR, Dalkin BL, et al. Prostate-specific antigen obtained under optimal conditions determines extracapsular adenocarcinoma of the prostate. Br J Urol 1995;75:21-25.
18. Narayan P, Gajendran V, Taylor SP, Tewari A, Presti JC Jr, Leidich R, et al. The role of transrectal ultrasound-guided biopsybased staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 1995;46:205-212.
19. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2000;163:174-178.
20. Egawa S, Suyama K, Matsumoto K, Satoh T, Uchida T, Kuwao S, et al. Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 1998;52:433-440.
21. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz VS, Myers RP, et al. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 2001;91:2196-2204.
22. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994;152:1843-1849.
23. Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, et al. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer 1999;85:1293-1299.
24. Ahlgren G, Falkmer U, Gadaleanu V, Abrahamsson PA. Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer. Eur Urol 1999;36:314-319.
25. Ohori M, Egawa S, Shinohara K, Wheeler TM, Scardino PT. Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. Br J Urol 1994;74:72-79.
26. McSherry SA, Levy F, Schiebler ML, Keefe B, Dent GA, Mohler JL. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 1991;146:85-89.
27. Heiken JP, Forman HP, Brown JJ. Neoplasms of the bladder, prostate, and testis. Radiol Clin North Am 1994;32:81-98.
28. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, et al. The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150:110-114.
29. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002;12:2294-2302.
30. Augustin H, Fritz GA, Ehammer T, Auprich M, Pummer K. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol 2009;50:562-569.
31. Fütterer JJ, Engelbrecht MR, Huisman HJ, Jager GJ, Hulsbergenvan De Kaa CA, Witjes JA, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005;237:541-549.
32. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-488.
33. Graefen M, Hammerer P, Michl U, Noldus J, Haese A, Henke RP, et al. Incidence of positive surgical margins after biopsyselected nerve-sparing radical prostatectomy. Urology 1998;51: 437-442.
34. Sanwick JM, Dalkin BL, Nagle RB. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology 1998;52:814-818.